Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
Lilly, J&J launches top Clarivate's Drugs to Watch 2026 report
Two investigational cardiometabolic drugs from Eli Lilly stand out in Clarivate's annual Drugs to Watch report. J&J also has two drugs on the list.
Kevin Dunleavy
Jan 7, 2026 9:28am
Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech
Jan 7, 2026 8:35am
J&J will appeal $1.5B verdict in record-breaking talc award
Dec 23, 2025 11:06am
FDA approves J&J's new challenge to Tagrisso
Dec 18, 2025 10:40am
ImmunityBio's Anktiva hits the mark in bladder cancer subtype
Dec 17, 2025 9:35am
FDA 'proactively' awards J&J a national priority review voucher
Dec 15, 2025 12:33pm
